Peritumoral hyperplasia of the liver: A response to portal vein invasion by hypervascular neoplasms

Histopathology

Volumn 62, Issue 3, 2013, Pages 458-464

  Arnason, Thomas ^a   Fleming, Kirsten E ^a   Wanless, Ian R ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Focal nodular hyperplasia; Glutamine synthetase; Liver; Neuroendocrine tumour; Peritumoral hyperplasia

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN 7; EOSIN; GLUTAMATE AMMONIA LIGASE; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CLINICAL ARTICLE; COLON CARCINOMA; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ATROPHY; LIVER CELL; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER PERITUMORAL HYPERPLASIA; LIVER TUMOR; MALE; NEUROENDOCRINE TUMOR; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TISSUE SECTION; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; ANTIGENS, CD34; FEMALE; GLUTAMATE-AMMONIA LIGASE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; YOUNG ADULT;

EID: 84872651156     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12032     Document Type: Article

References (24)

1. Saxena R, Humphreys S, Williams R, Portmann B. Nodular hyperplasia surrounding fibrolamellar carcinoma: a zone of arterialized liver parenchyma. Histopathology 1994; 25; 275-278.
2. Wanless IR. Focal nodular hyperplasia of the liver: comments on the pathogenesis. Arch. Pathol. Lab. Med. 2000; 124; 1105-1107.
3. Bralet MP, Terris B, Vilgrain V et al. Epithelioid hemangioendothelioma, multiple focal nodular hyperplasias and cavernous hemangiomas of the liver: an unusual association. Arch. Pathol. Lab. Med. 1999; 123; 846-849.
4. Berman MM, Libbey NP, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma-an atypical variant with a favorable prognosis. Cancer 1980; 46; 1448-1455.
5. Slavutin LJ, Diamond N. Case report Hepatocellular carcinoma with lamellar fibrosis: an important histological variant. Pathology 1981; 13; 775-781.
6. Farhi DC, Shikes RH, Silverberg SG. Ultrastructure of fibrolamellar oncocytic hepatoma. Cancer 1982; 50; 702-709.
7. Sumithran E. Fibrolamellar carcinoma of the liver. Am. J. Clin. Pathol. 1984; 82; 633-634.
8. Saul SH, Titelbaum DS, Gansler TS et al. The fibrolamellar variant of hepatocellular carcinoma Its association with focal nodular hyperplasia. Cancer 1987; 60; 3049-3055.
9. Davis M, Portmann B, Searle M, Wright R, Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. BMJ 1975; 4; 496-498.
10. Chen TC, Chou TB, Ng KF, Hsieh LL, Chou YH. Hepatocellular carcinoma associated with focal nodular hyperplasia Report of a case with clonal analysis. Virchows Arch. 2001; 438; 408-411.
11. Coopersmith CM, Lowell JA, Hassan A, Howard TK. Hepatocellular carcinoma in a patient with focal nodular hyperplasia. HPB (Oxf.) 2002; 4; 135-138.
12. Zhang SH, Cong WM, Wu MC. Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis. J. Clin. Pathol. 2004; 57; 556-559.
13. Gutweiler JR, Yu DC, Kim HB et al. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J. Pediatr. Surg. 2008; 43; 2297-2300.
14. Goodman ZD, Terracciano LM, Wee A. Tumours and tumour-like lesions of the liver. In Burt AD, Portmann BC, Ferrell L, eds. MacSween's pathology of the liver, 6th edn. Edinburgh: Churchill Livingstone Elsevier, 2012; 766-768.
15. Theuerkauf I, Zhou H, Fischer HP. Immunohistochemical patterns of human liver sinusoids under different conditions of pathologic perfusion. Virchows Arch. 2001; 438; 498-504.
16. Ferrara N, LeCouter J, Lin R, Peale F. EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors. Biochim. Biophys. Acta 2004; 1654; 69-78.
17. LeCouter J, Moritz DR, Li B et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003; 299; 890-893.
18. Orsatti G, Hytiroglou P, Thung SN, Ishak KG, Paronetto F. Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver 1997; 17; 152-156.
19. Fleming K, Wanless IR. Hepatic glutamine synthetase expression in cirrhosis, veno-occlusive disease, adjacent to mass lesions, and focal nodular hyperplasia (FNH) [abstract]. Mod. Pathol. 2010; 23(S1); 355.
20. D'Ambrosio R, Aghemo A, Grazia RM et al. A morphometric and immunohistochemical study to assess the benefit of an svr in HCV cirrhotic patients. Hepatology 2012; 56; 532-543.
21. Bioulac-Sage P, Laumonier H, Rullier A et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int. 2009; 29; 459-465.
22. Gebhardt R, Baldysiak-Figiel A, Krugel V, Ueberham E, Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog. Histochem. Cytochem. 2007; 41; 201-266.
23. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J. Hepatol. 2008; 48; 163-170.
24. Rebouissou S, Couchy G, Libbrecht L et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J. Hepatol. 2008; 49; 61-71.